Our Bobcats to Bobcats (B2B) Scholarship Program started in May 2020 as an emergency response to COVID-19. To date, 241 students were able to stay in school thanks to this scholarship. Your gift of scholarship support will keep educational dreams alive as the pandemic lingers on.
Bobcats to Bobcats - Scholarship Program
Immediate-use Scholarships
B2B scholarships are immediate-use scholarships to assist competitive students enrolling for the fall 2021 semester.
- Scholarships of at least $1,000 per student will be awarded to those who qualify for financial aid and enroll for classes beginning in the fall of 2021 for the academic year 2021-2022.
- No administrative fees of any kind are assessed or deducted.
- Students awarded will be incoming freshmen as well as returning students.
Grateful Students
EMMA ROMAN, '23
“My career goals are simple, I want to inspire and build resilience in the next generation as an educator. I am so honored to receive this scholarship; I’m supporting myself through college and it allows me to focus more time and energy on my studies.”
EVAN JELLISON, '22
"My experience at Texas State has been defined by a feeling of inclusion and the belief that I can do anything I put my mind to. Your donation does so much more than help students like myself financially."
KENDALLE HOWARD, '23
“With the start of this new academic journey, I will be entering Texas State University for the first time with more financial security. For that, I will be forever grateful.”
QY' DARRIUS MCEACHERN, '22
"My career goals are focused on supporting young people as they transition from secondary school to higher education. I will continue to pay forward your generosity to others."
ANGELA MCINERNEY, '23
"This scholarship will help me pay off my tuition so that I can focus on working to better my education. You have removed some of the weight from me and my mother's shoulders this year."
Bobcats Make the Difference
Managing an Evolving COVID-19
As the COVID-19 Pandemic enters the third year, its impact has changed in some important ways. With the development of safe and effective vaccines, the expanded availability of testing, and therapeutic agents that decrease the risk of severe illness both in and out of the hospital, we are seeing a different pattern of disease emerging. While Omicron subvariants continue to cause new infections, the incidence of severe illness appears lower and fewer hospitalizations are occurring than during previous waves of infection. This is most likely due to rising population immunity associated with vaccination and natural infection. However, COVID-19 will continue to circulate and require that we continue to assess risk and determine appropriate prevention measures.